ArticleInternational journal of pharmaceutics: X2025

Oral colon-targeted delivery of recombinant human MANF for alleviation of ulcerative colitis.

Jie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.